The PennZone

  • Home
  • Business
  • Health
  • Non-profit
  • Technology
  • Financial
  • Construction
  • Sports
  • Services

Dr. Jeff Gelblum Opens Jupiter Neurology Office with Infusion Center
The PennZone/10287893

Trending...
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
Jupiter Neurology and Infusion Center
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.

JUPITER, Fla. - PennZone -- To accommodate the exploding need for neurology services in Palm Beach, Martin, and St. Lucie counties, Jupiter Neurologist,  Dr. Jeff Gelblum, proudly announces the expansion of his in-office infusion center located at 601 University Boulevard, Suite 102, in Jupiter, Florida.

Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.

"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.

The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.

More on The PennZone
  • Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
  • Philadelphia Startup NoPlex Creates an ADHD/Neurodiversity-Focused Alternative to Productivity Apps
  • Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
  • Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
  • Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites

He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."

About Jeffrey Gelblum, MD, FAAN

Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.

Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.

Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/

Contact
First Choice Neurology
***@jmurrayassoc.com


Source: First Choice Neurology
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Together We Dance Shines at Newtown Holiday Parade
  • Dominic Pace Returns to the NCIS Franchise With Guest Role on NCIS: Origins
  • Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
  • UK Financial Ltd Completes Full Ecosystem Conversion With Three New ERC-3643 SEC-Ready Tokens As MCAT Deadline Closes Tonight
  • AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
  • Inkdnylon Expands National Uniform Embroidery Services
  • Appliance EMT Expands Appliance Repair Services to Portland, OR and Vancouver, WA
  • Next Week: The World's Best Young Pianists Arrive in Music City for the 2025 Nashville International Chopin Piano Competition
  • Revenue Optics Builds Out Its Dedicated Sales Recruiting Firm with Strategic Addition of Christine Schafer
  • Hydrofast Elevates the Holiday Season: The C100 Countertop RO System Merges Smart Tech with Wellness for the Perfect Christmas Gift
  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
  • Flower City Tattoo Convention Draws Record Attendance in Rochester, NY
  • KIKO NATION TOKEN (Official Release)
  • Verb™ Presents Features Vanguard Personalized Indexing: Utilizing Advanced Tax-Loss Harvesting Technology
  • Psoriasis Drugs Market Poised to Hit 20 Billion Dollars in 2025 says SNS Research in Latest Report
  • UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
  • 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
  • Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 565
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 218
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership - 105
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action

Similar on PennZone

  • Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
  • myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
  • Philadelphia Startup NoPlex Creates an ADHD/Neurodiversity-Focused Alternative to Productivity Apps
  • Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
  • Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
  • Hydrofast Elevates the Holiday Season: The C100 Countertop RO System Merges Smart Tech with Wellness for the Perfect Christmas Gift
  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us